An International Study on Pediatric Patients With Rare Tumors.
Recruiting
Observational Study
Paraganglioma/ Phaeochromocytoma
Melanoma and Other Malignant Neoplasms of Skin
Gastrointestinal Stromal Tumor (GIST)
Adrenocortical Tumor
Pancreatic Tumors
Esthesioneuroblastoma, Olfactory
Mesothelioma
Nasopharyngeal Carcinoma (NPC)
NUT Carcinoma
Pleuropulmonary Blastoma
Salivary Gland Tumors
Thymic Tumors
Thyroid Carcinoma
Appendiceal Cancers
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 6,250 (estimated)
- Sponsor
- Azienda Ospedaliera di Padova · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
* Written informed consent from the patient and/or the parent/legal guardian
Exclusion Criteria:
* Absence of Written informed con…
Contacts